BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 30209921)

  • 1. Fungal biofilms: From bench to bedside.
    Iñigo M; Del Pozo JL
    Rev Esp Quimioter; 2018 Sep; 31 Suppl 1(Suppl 1):35-38. PubMed ID: 30209921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fungal Biofilms: Update on Resistance.
    Borghi E; Borgo F; Morace G
    Adv Exp Med Biol; 2016; 931():37-47. PubMed ID: 27115411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tackling Fungal Resistance by Biofilm Inhibitors.
    Wu S; Wang Y; Liu N; Dong G; Sheng C
    J Med Chem; 2017 Mar; 60(6):2193-2211. PubMed ID: 28051303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid combinations containing natural products and antimicrobial drugs that interfere with bacterial and fungal biofilms.
    Zacchino SA; Butassi E; Cordisco E; Svetaz LA
    Phytomedicine; 2017 Dec; 37():14-26. PubMed ID: 29174600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal activity of a β-peptide in synthetic urine media: Toward materials-based approaches to reducing catheter-associated urinary tract fungal infections.
    Raman N; Lee MR; Rodríguez López AL; Palecek SP; Lynn DM
    Acta Biomater; 2016 Oct; 43():240-250. PubMed ID: 27422198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies in the discovery of novel antifungal scaffolds.
    Liu N; Wang C; Su H; Zhang W; Sheng C
    Future Med Chem; 2016 Aug; 8(12):1435-54. PubMed ID: 27463376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal therapy with an emphasis on biofilms.
    Pierce CG; Srinivasan A; Uppuluri P; Ramasubramanian AK; López-Ribot JL
    Curr Opin Pharmacol; 2013 Oct; 13(5):726-30. PubMed ID: 24011516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Echinocandins in Fungal Biofilm-Related Disease: Vascular Catheter-Related Infections, Immunomodulation, and Mucosal Surfaces.
    Katragkou A; Roilides E; Walsh TJ
    Clin Infect Dis; 2015 Dec; 61 Suppl 6():S622-9. PubMed ID: 26567280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Sources as Innovative Solutions Against Fungal Biofilms.
    Girardot M; Imbert C
    Adv Exp Med Biol; 2016; 931():105-25. PubMed ID: 27115410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activity of micafungin against Candida biofilms].
    Quindós G; Villar-Vidal M; Eraso E
    Rev Iberoam Micol; 2009 Mar; 26(1):49-55. PubMed ID: 19463277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fungal biofilm composition and opportunities in drug discovery.
    Reichhardt C; Stevens DA; Cegelski L
    Future Med Chem; 2016 Aug; 8(12):1455-68. PubMed ID: 27485639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination Therapy to Treat Fungal Biofilm-Based Infections.
    Tits J; Cammue BPA; Thevissen K
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal drug resistance of oral fungi.
    Niimi M; Firth NA; Cannon RD
    Odontology; 2010 Feb; 98(1):15-25. PubMed ID: 20155503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strength in numbers: antifungal strategies against fungal biofilms.
    Ramage G; Robertson SN; Williams C
    Int J Antimicrob Agents; 2014 Feb; 43(2):114-20. PubMed ID: 24359842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [How do fungal infections "escape" treatment? Resistance and resistance mechanisms].
    Morschhäuser J
    Pharm Unserer Zeit; 2003; 32(2):124-8. PubMed ID: 12677965
    [No Abstract]   [Full Text] [Related]  

  • 16. Antifungal drug resistance mechanisms in pathogenic fungi: from bench to bedside.
    Cuenca-Estrella M
    Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():54-9. PubMed ID: 24372680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging moulds: epidemiological trends and antifungal resistance.
    Miceli MH; Lee SA
    Mycoses; 2011 Nov; 54(6):e666-78. PubMed ID: 21672045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of fungal pathogens and antifungal coatings in medical device infections.
    Giles C; Lamont-Friedrich SJ; Michl TD; Griesser HJ; Coad BR
    Biotechnol Adv; 2018; 36(1):264-280. PubMed ID: 29199134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress and prospects for targeting Hsp90 to treat fungal infections.
    Veri A; Cowen LE
    Parasitology; 2014 Aug; 141(9):1127-37. PubMed ID: 24560124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms.
    Delattin N; Cammue BP; Thevissen K
    Future Med Chem; 2014 Jan; 6(1):77-90. PubMed ID: 24358949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.